Respiratory Viruses in Nosocomial Pneumonia: An Evolving Paradigm
Related Experiment Video
Updated: Jul 18, 2025
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Marya D Zilberbeg1, Imran Khan2, Andrew F Shorr2
1EviMed Research Group, LLC, P.O. Box 303, Goshen, MA 01032, USA.
Abstract:
Nosocomial pneumonia (NP) represents a leading cause of morbidity and mortality in hospitalized patients. Historically, clinicians have considered hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), which comprise NP, to be essentially bacterial processes. As such, patients suspected of having either HAP or VAP are initially treated with broad-spectrum antibiotics, and few clinicians search for a possible culprit virus. Recent reports which build on earlier studies, however, indicate that viruses likely play an important role in NP. Studies employing viral diagnostics as part of the evaluation for NP indicate that common respiratory viruses can spread nosocomially and lead to HAP and VAP. Similarly, studies of the general epidemiology of respiratory viral infections, such as influenza, respiratory syncytial virus, adenovirus, and rhinovirus, confirm that these pathogens are important causes of NP, especially among immunosuppressed and pediatric patients. More importantly, these more contemporary analyses reveal that one cannot, based on clinical characteristics, distinguish a viral from a bacterial cause of NP. Additionally, viral HAP and VAP result in crude mortality rates that rival or exceed those reported in bacterial NP. Rigorous prospective, multicenter trials are needed to confirm the significance of respiratory viruses in NP, as are studies of novel therapeutics for these viral infections.
Insights
Viruses are significant causes of nosocomial pneumonia (NP), including hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). Differentiating viral from bacterial NP is challenging, and viral infections carry comparable mortality rates.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Virology
Background:
- Nosocomial pneumonia (NP), encompassing hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), is a major cause of hospital morbidity and mortality.
- Historically, NP has been predominantly viewed as a bacterial infection, leading to routine antibiotic treatment.
- Emerging evidence suggests a significant, often overlooked, role for viruses in the pathogenesis of NP.
Purpose of the Study:
- To highlight the underappreciated role of viral pathogens in nosocomial pneumonia.
- To emphasize the diagnostic challenges in differentiating viral from bacterial NP.
- To underscore the clinical significance and mortality associated with viral NP.
Main Methods:
- Review of recent studies and epidemiological data on respiratory viral infections in hospitalized patients.
- Analysis of viral diagnostics in the context of NP evaluation.
- Comparison of clinical characteristics and outcomes of viral versus bacterial NP.
Main Results:
- Common respiratory viruses (e.g., influenza, RSV, adenovirus, rhinovirus) are identified as significant causes of HAP and VAP.
- Clinical presentation does not reliably distinguish between viral and bacterial NP.
- Viral NP exhibits mortality rates comparable to or exceeding those of bacterial NP, particularly in vulnerable populations like immunosuppressed and pediatric patients.
Conclusions:
- Viruses are critical and frequent etiologies of nosocomial pneumonia that require greater clinical attention.
- Current diagnostic and treatment paradigms for NP may be inadequate in addressing viral contributions.
- Further research, including prospective trials and novel therapeutics, is essential to fully understand and manage viral NP.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Acute Respiratory Failure-III